Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05752552 |
Title | Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | DeuterOncology |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | NLD | FRA | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Institut Roi Albert II - UC Louvain | RECRUITING | Bruxelles | Belgium | Details | ||
UZA | RECRUITING | Edegem | Belgium | Details | ||
Universitair Ziekenhuis Gent | RECRUITING | Gent | 9000 | Belgium | Details | |
Centre Georges-François Leclerc - CHU Dijon | NOT_YET_RECRUITING | Dijon | France | Details | ||
Institut Cœur Poumon - CHU Lille | NOT_YET_RECRUITING | Lille | France | Details | ||
Centre Léon Bérard | NOT_YET_RECRUITING | Lyon | France | Details | ||
Radboud UMC | RECRUITING | Nijmegen | Netherlands | Details | ||
Erasmus Medical Centre | RECRUITING | Rotterdam | Netherlands | Details |